Results 201 to 210 of about 46,293 (304)

Design and Synthesis of Novel Purine Analogues as Potential IL-1β Inhibitors Targeting Vascular Inflammation. [PDF]

open access: yesChem Biodivers
Pournara DT   +6 more
europepmc   +1 more source

Separación y recuperación de fosfato y amonio de purines mediante sorción con zeolites sintéticas

open access: yes
Los purines de cerdo han sido tradicionalmente un problema medioambiental debido a su potencial para contaminar el suelo y las aguas cercanas. La gran concentración de granjas en zonas concretas y el hecho de que los purines no se puedan transportar a ...
Muiños Lázaro, Laura
core  

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu   +10 more
wiley   +1 more source

Enteric glia and purinergic signaling in health and disease. [PDF]

open access: yesNeuropharmacology
Gulbransen BD, Verkhratsky A, Parpura V.
europepmc   +1 more source

Synthesis of New Push-Pull Purines from 9-Alkyl Substituted 2,6-Dichloropurines

open access: yes
Push-pull purine derivatives are attractive as sensors and reporters for biological applications. Recently the fluorescent purines as materials for electronic devices have also been developed.
Šišuļins, Andrejs   +2 more
core  

Aspartate Transporter SLC1A3 Promotes Colorectal Cancer via MDM2‐p53 Pathway and M2 Macrophage Polarization

open access: yesCancer Science, EarlyView.
SLC1A3 promotes colorectal cancer progression by transporting extracellular aspartate into tumor cells, thereby activating the PKC/MDM2/p53 pathway to enhance proliferation. Reduced extracellular aspartate, combined with p53‐dependent suppression of CSF2 and IL17C, drives M2 macrophage polarization via immune modulation, macrophage recruitment, and M2 ...
Chao Deng   +9 more
wiley   +1 more source

MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy

open access: yesCancer Science, EarlyView.
MTAP deletion creates a therapeutically actionable metabolic vulnerability through MTA accumulation and PRMT5 dependency. This review summarizes the biochemical basis of MTAP‐directed synthetic lethality, emerging PRMT5/MAT2A inhibitors, clinicogenomic features of MTAP‐deleted tumors, and future strategies for precision oncology.
Hiroaki Ikushima, Hidenori Kage
wiley   +1 more source

Home - About - Disclaimer - Privacy